Navigation Links
China Medicine Corporation Achieves Major Milestone for rADTZ
Date:4/24/2009

GUANGZHOU, China, April 24 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a developer and leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China (PRC), today announced that Guangzhou Co-Win Bioengineering Co., Ltd. ("Co-Win") has received a manufacturing license for premixed feed additive and a manufacturing license for feed additive for its production facility that is leased from Guangzhou Municipal Microbe Research Institute. The Company owns 70% of Co-Win's equity interests through the Company's 100% equity ownership of Guangzhou Konzern Medicine Co., Ltd. The two licenses are both valid for five years from March 23, 2009. Since our novel product, recombinant aflatoxin detoxifizyme (rADTZ) is also a feed additive, the two licenses gave Co-Win necessary credits in terms of its ability of manufacturing feed additives and therefore further enable Co-Win to be eligible for manufacturing a new feed additive, rADTZ. In addition, with both manufacturing licenses and the fact Co-Win has submitted the application for rADTZ's permit, China Medicine may enter into a trial production and trial sales phase for rADTZ.

The production facility will be exclusively used to manufacture rADTZ, a novel product that has the potential to detoxify aflatoxin, a cancer causing agent in food and feed. "We are very pleased to be granted manufacturing licenses for premixed feed additive and feed additive, which represents a major milestone in the evolution of our product," said Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation.

China's Ministry of Agriculture granted the two manufacturing licenses after inspecting the related facility and evaluating Co-Win's management capability, quality control system, human resource professionalism and expertise. Co-Win is also currently waiting to receive a product safety test report and a product effectiveness test report for rADTZ from the Chinese Academy of Agriculture and Science. Upon receiving these reports, Co-Win's application for rADTZ's product permit from China's Ministry of Agriculture can be finalized.

"We are moving fast towards preparing for the commercialization of rADTZ. We have submitted the application for the rADTZ's product permit. We anticipate that such permit is to be granted within the next two or three months. We may start to have trial sales of rADTZ in the second quarter of 2009. We believe that our strategy to develop rADTZ will bring China Medicine to another level altogether, where we will be able to expand our product offering to address China's $404 million feed market, which is approximately 10% of the total feed market in China," concluded Mr. Senshan Yang.

About China Medicine Corporation

China Medicine Corporation is a developer and leading distributor that discovers and develops medical formulations and distributes approximately 2,400 specifications of pharmaceutical products in China, including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to 1,788 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

    For more information, please contact:

    China Medicine Corp
     Ms. Huizhen Yu, CFO
     Tel:   +86-20-8739-1718
     Email: konzern08@163.com

    CCG Investor Relations Inc.
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com

'/>"/>
SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, courtesy of leaders in the nursing and ... within the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... , ... W.S. Badger Co. Inc ., the maker of certified organic ... Works Award for its use of effective workplace strategies to increase business and employee ... by the Families and Work Institute (FWI) and the Society for Human Resource Management ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 The ... manufacturers, health insurance companies all falling under its umbrella.  ... companies. While not often talked about, these healthcare companies ... United States is by far the largest ... Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
Breaking Medicine Technology: